Onconova Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Onconova Therapeutics's balance sheet done over the years? Its assets were worth $22,683,000 last year, which is less than in the previous period. 53% of Onconova Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $12,011,000, which means an increase by 9% compared compared to last year.
Debt to Assets
| 2014 | 47337000 | 23.71M | 50.1% |
|---|---|---|---|
| 2015 | 23445000 | 12.60M | 53.76% |
| 2016 | 23233000 | 18.10M | 77.93% |
| 2017 | 4979000 | 15.84M | 318.14% |
| 2018 | 17923000 | 12.53M | 69.94% |
| 2019 | 23674000 | 12.1M | 51.11% |
| 2020 | 19986000 | 13.81M | 69.1% |
| 2021 | 55478000 | 9.35M | 16.87% |
| 2022 | 39372000 | 11.06M | 28.1% |
| 2023 | 22683000 | 12.01M | 52.95% |
ONTX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 20.82M | 38.75M | 55.07M | 19.02M | 22.72M | 16.97M | 4.02M | 21.4M | 19.79M | 43.58M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 18K | 29K | 28K | 37K | 98K | 35K | 59K | 31K | 1.50M | 0 |
Inventory | 1.42M | 97K | 29K | 90K | 25K | 0 | 0 | 1.56M | 1.68M | 0 |
Other current assets | 401K | 561K | 332K | 722K | 650K | 760K | 820K | 73K | 195K | 387K |
Total current assets | 22.66M | 39.34M | 55.43M | 19.78M | 23.47M | 17.76M | 4.90M | 23.06M | 23.18M | 46.90M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 22K | 24K | 38K | 52K | 50K | 9K | 64K | 152K | 248K | 420K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 1K | 1K | 10K | 150K | 150K | 149K | 12K | 12K | 12K | 12K |
Total non-current assets | 23K | 25K | 48K | 202K | 200K | 158K | 76K | 164K | 260K | 432K |
Total assets | 22.68M | 39.37M | 55.47M | 19.98M | 23.67M | 17.92M | 4.97M | 23.23M | 23.44M | 47.33M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 226K | 226K | 226K | 226K | 226K | 226K | 455K | 455K | 455K | 455K |
Short term debt | -3.37T | 0 | 0 | 0 | 0 | 4.16M | 0 | 4.18M | 3.72M | 5.77M |
Total current liabilities | 9.22M | 8.04M | 6.11M | 10.02M | 8.29M | 8.43M | 9.97M | 10.16M | 7.60M | 10.25M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 321K | 113K | 176K | 1.77M | 3.40M | 0 | 1K |
Total non-current liabilities | 2.79M | 3.01M | 3.24M | 3.79M | 3.80M | 4.09M | 5.86M | 7.94M | 5M | 13.45M |
Total liabilities | 12.01M | 11.06M | 9.35M | 13.81M | 12.1M | 12.53M | 15.84M | 18.10M | 12.60M | 23.71M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |